- Home
- SACH vs RENB Comparison
SACH vs RENB Comparison
Compare SACH & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SACH
- RENB
- Stock Information
- Founded
- SACH 2010
- RENB 2011
- Country
- SACH United States
- RENB United States
- Employees
- SACH N/A
- RENB N/A
- Industry
- SACH Real Estate Investment Trusts
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- SACH Real Estate
- RENB Health Care
- Exchange
- SACH Nasdaq
- RENB Nasdaq
- Market Cap
- SACH 54.4M
- RENB 57.7M
- IPO Year
- SACH 2017
- RENB N/A
- Fundamental
- Price
- SACH $1.25
- RENB $0.19
- Analyst Decision
- SACH Hold
- RENB
- Analyst Count
- SACH 4
- RENB 0
- Target Price
- SACH $2.25
- RENB N/A
- AVG Volume (30 Days)
- SACH 246.4K
- RENB 907.8K
- Earning Date
- SACH 11-13-2025
- RENB 11-13-2025
- Dividend Yield
- SACH 15.94%
- RENB N/A
- EPS Growth
- SACH N/A
- RENB N/A
- EPS
- SACH N/A
- RENB N/A
- Revenue
- SACH N/A
- RENB N/A
- Revenue This Year
- SACH N/A
- RENB N/A
- Revenue Next Year
- SACH $7.74
- RENB N/A
- P/E Ratio
- SACH N/A
- RENB N/A
- Revenue Growth
- SACH N/A
- RENB N/A
- 52 Week Low
- SACH $0.80
- RENB $0.18
- 52 Week High
- SACH $2.70
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- SACH 52.08
- RENB 36.34
- Support Level
- SACH $1.26
- RENB $0.18
- Resistance Level
- SACH $1.35
- RENB $0.22
- Average True Range (ATR)
- SACH 0.06
- RENB 0.02
- MACD
- SACH 0.00
- RENB -0.00
- Stochastic Oscillator
- SACH 44.74
- RENB 10.48
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.